Change history
03 May 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00270-021-02855-9
References
Williams NR, et al. The pulmicc trial provides control data for colorectal lung metastases amenable to local treatments. CardioVascIntervRadiol. 2020. https://doi.org/10.1007/s00270-020-02711-2.
Zhong J, et al. Long-term outcomes in percutaneous radiofrequency ablation for histologically proven colorectal lung metastasis. CardioVasc Interv Radiol. 2020;43(12):1900–7.
Milosevic M, et al. Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients – control survival is much better than previously assumed. Colorectal Dis. 2020;22(10):1314–24.
Treasure T, et al. Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial. Trials. 2019;20(1):718.
Mohamed F, et al. Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance. BJS (Br J Surg). 2020;107(8):943–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors that they have declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised due to a retrospective Open Access cancellation.
Rights and permissions
About this article
Cite this article
Bhartia, B., Zhong, J., Chaudhuri, N. et al. Reply to: The PulMiCC Trial Provides Control Data for Colorectal Lung Metastases Amenable to Local Treatments. Cardiovasc Intervent Radiol 44, 656–657 (2021). https://doi.org/10.1007/s00270-020-02740-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-020-02740-x